New research, led by scientists from the Seaver Autism Center for Research and Treatment at Mount Sinai and published in ...

A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.

The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...

Mast and Herper have covered rare disease issues for a combined three decades. As part of the reporting, Mast spent two days in the Bay Area with Matt Wilsey and Grace. Jason is a general assignment ...

Asia-Pacific emerges as a key growth region. The global DNA diagnostics market is projected to grow from $13.2b in 2025 to ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by ...

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

It’s a bit like giving the soil a DNA test.” A new droplet digital PCR (ddPCR) method quantifies root DNA directly from soil ...

As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses. The tool's ability to frequently and automatically ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...